文献速递糖尿病骨质疏松与钙磷/甲状旁腺

儿童青少年1型糖尿病与骨密度:Meta分析

Bone Mineral Density and Type 1 Diabetes in Children and Adolescents: A Meta-analysis.
PubMed 文献 · Diabetes Care · 2021-07-20

该系统综述与Meta分析纳入46项研究(2617例1型糖尿病 youth 与3851例对照),评估DXA、pQCT和QUS测量的骨密度。结果显示1型糖尿病 youth 全身、腰椎、股骨及胫骨/桡骨小梁、指骨和跟骨骨密度均显著低于对照,提示骨发育异常,建议考虑常规评估骨密度。

要点

  • 1型糖尿病 youth 多部位骨密度显著低于对照。
  • 全身骨密度降低与年龄较大相关,与病程和HbA1c无关。
  • 建议对所有1型糖尿病 youth 考虑常规评估骨密度。

核心结论

  • 1型糖尿病 youth 骨发育异常,多模态评估均显示骨密度降低。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed、Embase、Scopus和Web of Science(1990年1月1日至2020年12月31日)。
  • 纳入46项横断面或队列研究,共2617例1型糖尿病 youth 和3851例匹配对照,平均年龄12.6±2.3岁。

主要发现

  • 全身骨密度加权均数差(WMD)为-0.04 g/cm2(95%CI -0.06至-0.02;P=0.0006)。
  • 腰椎骨密度WMD为-0.02 g/cm2(95%CI -0.03至-0.0;P=0.01)。
  • 股骨骨密度WMD为-0.04 g/cm2(95%CI -0.05至-0.03;P<0.00001)。
  • 胫骨小梁骨密度WMD为-11.32 g/cm3(95%CI -17.33至-5.30;P=0.0002),桡骨小梁为-0.91 g/cm3(95%CI -1.55至-0.27;P=0.005)。
  • 指骨骨密度WMD为-0.32 g/cm3(95%CI -0.38至-0.25;P<0.00001),跟骨标准化均数差为-0.69 g/cm3(95%CI -1.11至-0.26;P=0.001)。

关键数值与推荐

  • Meta回归显示全身骨密度与年龄较大相关(系数-0.0063,95%CI -0.0095至-0.0031;P=0.002),与糖尿病病程或HbA1c无关。

临床怎么用

  • 对1型糖尿病 youth 应考虑常规评估骨密度。

局限性

  • 使用QUS和pQCT的研究数量较少,且并非所有研究均使用骨密度z评分。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is substantial evidence that adults with type 1 diabetes have reduced bone mineral density (BMD); however, findings in youth are inconsistent. PURPOSE: To perform a systematic review and meta-analysis of BMD in youth with type 1 diabetes using multiple modalities: DXA, peripheral quantitative computed tomography (pQCT), and/or quantitative ultrasound (QUS). DATA SOURCES: PubMed, Embase, Scopus, and Web of Science from 1 January 1990 to 31 December 2020, limited to humans, without language restriction. STUDY SELECTION: Inclusion criteria were as follows: cross-sectional or cohort studies that included BMD measured by DXA, pQCT, or QUS in youth (aged <20 years) with type 1 diabetes and matched control subjects. DATA EXTRACTION: We collected data for total body, lumbar spine, and femoral BMD (DXA); tibia, radius, and lumbar spine (pQCT); and phalanx and calcaneum (QUS). Weighted mean difference (WMD) or standardized mean difference was estimated and meta-regression was performed with age, diabetes duration, and HbA1c as covariates. DATA SYNTHESIS: We identified 1,300 nonduplicate studies; 46 met the inclusion criteria, including 2,617 case and 3,851 control subjects. Mean ± SD age was 12.6 ± 2.3 years. Youth with type 1 diabetes had lower BMD: total body (WMD -0.04 g/cm2, 95% CI -0.06 to -0.02; P = 0.0006), lumbar spine (-0.02 g/cm2, -0.03 to -0.0; P = 0.01), femur (-0.04 g/cm2, -0.05 to -0.03; P < 0.00001), tibial trabecular (-11.32 g/cm3, -17.33 to -5.30; P = 0.0002), radial trabecular (-0.91 g/cm3, -1.55 to -0.27; P = 0.005); phalangeal (-0.32 g/cm3, -0.38 to -0.25; P < 0.00001), and calcaneal (standardized mean difference -0.69 g/cm3, -1.11 to -0.26; P = 0.001). With use of meta-regression, total body BMD was associated with older age (coefficient -0.0063, -0.0095 to -0.0031; P = 0.002) but not with longer diabetes duration or HbA1c. LIMITATIONS: Meta-analysis was limited by the small number of studies with use of QUS and pQCT and by lack of use of BMD z scores in all studies. CONCLUSIONS: Bone development is abnormal in youth with type 1 diabetes, assessed by multiple modalities. Routine assessment of BMD should be considered in all youth with type 1 diabetes.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Loxton P, Narayan K, Munns CF, et al. Bone Mineral Density and Type 1 Diabetes in Children and Adolescents: A Meta-analysis. Diabetes Care. 2021. PMID: 34285100. doi:10.2337/dc20-3128

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。